Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma

Journal of Supportive Oncology

Volumn 5, Issue 5, 2007, Pages 231-235

  Vera Llonch, Montserrat ^a,b,c,d,e   Oster, Gerry ^a,b,c,d,e   Ford, Colleen M ^a,b,c,d,e   Lu, John ^a,b,c,d,e   Sonis, Stephen ^a,b,c,d,e  

^a POLICY ANALYSIS INC PAI   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE; MELPHALAN; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; ECONOMIC ASPECT; ERYTHEMA; FEMALE; FEVER; GRAFT RECIPIENT; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOUTH INFECTION; MOUTH ULCER; MULTIPLE MYELOMA; OROPHARYNX; RETROSPECTIVE STUDY; STOMATITIS; TOTAL PARENTERAL NUTRITION; VALIDATION PROCESS; WHOLE BODY RADIATION;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS, ALKYLATING; BOSTON; COSTS AND COST ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LENGTH OF STAY; MALE; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; ORAL ULCER; PARENTERAL NUTRITION, TOTAL; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STOMATITIS; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 34249846665     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer 2000;8:33-39. [10650895]
2. Ruescher TJ, Sodeifi A, Scrivani SJ, Kaban LB, Sonis ST. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 1998;82:2275-2281.[9610710]
3. Sonis ST, Oster G, Fuchs H, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 2001;19:2201-2205.[11304772]
4. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003;98:1531-1539.[14508842]
5. Spielberger R, Stiff P, Bensinger W, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004;351:2590-2598. [15602019]
6. Ferrara F, Palmieri S, Viola A, et al. Outpatient-based peripheral blood stem cell transplantation for patients with multiple myeloma. Hematol J 2004;5:222-226.[15167908]
7. Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury; pathogenesis, measurement epidemiology, and consequences for patients. Cancer 2004;100(9 suppl):1995-2025. [15108222]
8. Monopoli M, Woo S, Valley M, Sonis S. A site-based scoring system of chemotherapy-induced oral mucositis in bone marrow transplant recipients. Presented at the Sixth Annual Meeting of the Society of Oral Oncology. Keystone, CO; August 1, 1991. Abstract.
9. Rapoport AP, Miller Watelet LF, Linder T, et al. Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. J Clin Oncol 1999;17:2446-2453. [10561308]
10. 2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis for the Intergroupe Francophone du Myelome 9502 randomized trial. Blood 2002;99:731-735.[11806971]
11. Jantunen E, Kuittinen T, Nousiainen T. A pilot stucly of the feasibility and efficacy of amifostine preceding high-dose melphalan with autologous stem cell support in myeloma patients. Leuk Lymphoma 2002;43:1961-1965.[12481892]
12. Wardley AM, Jayson GC, Swindell R, et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol 2000;110:292-299.[10971384]